ASH international clinical collaboration replicates high cure rate of APL in developing countries
Data published online today in Blood, the Journal of the American Society of Hematology (ASH) describe the work of an ASH international clinical network collaborative focused on modernizing treatment protocols for patien ...
Cancer
Jan 14, 2013 |
not rated yet |
0
Merck warns doctors to stop prescribing Tredaptive
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Medications
Jan 11, 2013 |
1 / 5 (1) |
0
Scientists say vaccine temporarily brakes HIV
A team of Spanish researchers say they have developed a therapeutic vaccine that can temporarily brake growth of the HIV virus in infected patients.
HIV & AIDS
Jan 03, 2013 |
4.7 / 5 (3) |
3
One man's harrowing battle with hepatitis C
(HealthDay)—Ted Adamson's liver had been so ravaged by the hepatitis C virus that he was nearly at the point of needing a liver transplant. Yet he had no symptoms. None. He didn't even feel tired.
Diseases, Conditions, Syndromes
Dec 21, 2012 |
5 / 5 (1) |
0
Data suggest smoking doesn't impact RA treatment response
(HealthDay)—For patients with early rheumatoid arthritis (RA), smoking status does not impact treatment response to early combination therapy or initial methotrexate treatment with step-up therapy, according ...
Arthritis & Rheumatism
Dec 21, 2012 |
not rated yet |
0
New whole plant therapy shows promise as an effective and economical treatment for malaria
In the worldwide battle to curtail malaria, one of the most prevalent and deadly infectious diseases of the developing world, drug after drug has fallen by the wayside as the malaria parasite has become resistant ...
Diseases, Conditions, Syndromes
Dec 20, 2012 |
4.8 / 5 (6) |
1
|
Combination therapy may help decrease sleep apnea symptoms at higher altitudes
For individuals with obstructive sleep apnea traveling to higher altitudes (which may exacerbate symptoms), use of a combination therapy resulted in improvement in symptoms including reduced insomnia and better control of ...
Sleep apnea
Dec 11, 2012 |
not rated yet |
0
Caution still advised despite ever-improving HIV drugs
Combination therapies for AIDS are becoming increasingly effective, but they cannot protect against other sexually transmitted illnesses. It is unsafe for patients taking antiretroviral drugs to stop using ...
HIV & AIDS
Nov 30, 2012 |
not rated yet |
0
Fenofibrate / simvastatin benefit in dyslipidemia explored
(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless of ...
Diabetes
Nov 01, 2012 |
4.5 / 5 (2) |
0
Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy
The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological ...
Cancer
Nov 01, 2012 |
5 / 5 (1) |
0
Nearly half of US adults with high blood pressure have it under control
Nearly half of U.S. adults with high blood pressure had their blood pressure under control by the end of 2010—a significant increase from the start of the decade, researchers reported in the American Heart Association journal ...
Cardiology
Oct 22, 2012 |
not rated yet |
0
|
Pulmonary hypertension combination therapy may lead to greater disease burden
Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding ...
Diseases, Conditions, Syndromes
Oct 22, 2012 |
not rated yet |
0
New malaria drug requires just one dose and appears twice as effective as existing regimen
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with ...
Diseases, Conditions, Syndromes
Oct 17, 2012 |
not rated yet |
0
Researchers study 'ACT TIL' approach to treating metastatic melanoma
Researchers at Moffitt Cancer Center have carried out a clinical trial in which patients with metastatic melanoma were given chemotherapy and an immunotherapy of adoptive cell transfer (ACT) with tumor infiltrating lymphocytes ...
Immunology
Oct 17, 2012 |
not rated yet |
0
Additional medicines can reduce recurrence risk, but come with their own issues
After surgeons removed the tumor from her breast last November, Karen Hajiaskari, of Hamburg, N.Y., was deemed cancer-free. But for the next five years she will take a drug called tamoxifen, a medication that's commonly used ...
Cancer
Oct 07, 2012 |
5 / 5 (2) |
0
